Skip to main content

#151652

Anti-PRAF2 [SG36]

Cat. #151652

Anti-PRAF2 [SG36]

Cat. #: 151652

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: PRAF2

Class: Polyclonal

Application: WB

Reactivity: Mouse

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ingram Iaccarino

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-PRAF2 [SG36]
  • Research fields: Cell signaling and signal transduction
  • Clone: SG36
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Reactivity: Mouse
  • Host: Rabbit
  • Application: WB
  • Description: Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2
  • Immunogen: Recombinant full-length Praf2 of human origin fused to GST
  • Recommended controls: MDA-MB231 cells

Target Details

  • Target: PRAF2
  • Tissue cell line specificity: MDA-MB231 cells
  • Target background: Praf2 is a novel protein involved in endoplasmic reticulum to golgi transport. It has been found up-regulated in several cancers and it has been found to interact with Bcl-xL/Bcl-2

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Whole serum
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.